13D/G large-stake feed
Since 04 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.
Recent 13D/G signals
Start with holder, issuer/security, stake size, and SEC evidence.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Schedule 13D/G ownership events
Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.
Visible reports
6
Fresh large-stake filings promoted above the legacy table.
13D/13G mix
1/5
Active-intent candidates versus passive large-stake disclosures.
Largest visible stake
30%
Highest class ownership surfaced in the preview cards.
Newest evidence
15 May 2026
Use recency before treating an old large-stake story as fresh.
Signal checks
active/control intent, item text, amendments
large passive holder disclosure
ownership percent and share change
issuer, filer history, insider activity, 13F context
SEC-verifiable Schedule 13D/G path
Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.
SB INVESTMENT ADVISERS (UK) LTD filed Schedule 13G/A for Vir Biotechnology, Inc. (VIR). Reported class ownership: 6.5%. Ownership change: -2.9%. Share change: -17%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
Freebird Partners LP filed Schedule 13G/A for Ernexa Therapeutics Inc. (ERNA). Reported class ownership: 9.9%. Ownership change: 0%. Share change: -85%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
HALPERN JOHN D filed Schedule 13G/A for Ernexa Therapeutics Inc. (ERNA). Reported class ownership: 5.6%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
ADAR1 Capital Management, LLC filed Schedule 13G/A for Equillium, Inc. (EQ). Reported class ownership: 9.9%. Ownership change: 0%. Share change: +6.6%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
4338618 Canada Inc. filed Schedule 13G/A for BRP Inc. (DOO). Reported class ownership: 30%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
GENERAL ATLANTIC, L.P. filed Schedule 13D/A for ALKAMI TECHNOLOGY, INC. (ALKT). Reported class ownership: 18%. Ownership change: +1.8%. Share change: +11%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.